Merck & Co Inc (NYSE:MRK)
| 78.67 BATS BZX Real-Time Price As of 1:23pm ET |  -0.02 / -0.03%Today’s Change | 71.72 Today|||52-Week Range 87.80 | -3.83% Year-to-Date |
Latest MRK News | Press Releases
Today’s Trading
| Previous close | 78.69 |
| Today’s open | 79.05 |
| Day’s range | 78.40 - 79.22 |
| Volume | 3,940,422 |
| Average volume (3 months) | 11,905,794 |
| Market cap | $198.5B |
Data as of 1:23pm ET, 05/14/2021
Growth & Valuation
| Earnings growth (last year) | -27.21% |
| Earnings growth (this year) | +8.64% |
| Earnings growth (next 5 years) | +8.00% |
| Revenue growth (last year) | +3.06% |
| P/E ratio | 28.4 |
| Price/Sales | 4.33 |
| Price/Book | 7.84 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | +0.64 | +0.72% |
| ABBVAbbVie | +0.66 | +0.57% |
| LLYEli Lilly and Co | +1.86 | +0.95% |
| PFEPfizer | 0.00 | 0.00% |
Data as of 1:23pm ET, 05/14/2021
Financials
| Next reporting date | July 29, 2021 |
| EPS forecast (this quarter) | $1.60 |
| Annual revenue (last year) | $48.0B |
| Annual profit (last year) | $7.1B |
| Net profit margin | 14.72% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kenilworth, New Jersey |
Forecasts
